Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Efficacy of the Paclitaxel Eluting Hemodialysis Shunt Balloon Dilatation Catheter (APERTO) in Treatment of Hemodialysis Arteriovenous Fistulae Stenosis: A Prospective, Multicenter, Randomized, Controlled Clinical Study

NCT02962141 is registered in ClinicalTrials.gov with ZhuHai Cardionovum Medical Device Co., Ltd. as lead sponsor.

NCT NCT02962141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02962141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Efficacy of the Paclitaxel Eluting Hemodialysis Shunt Balloon Dilatation Catheter (APERTO) in Treatment of Hemodialysis Arteriovenous Fistulae Stenosis: A Prospective, Multicenter, Randomized, Controlled Clinical Study
Lead sponsor
ZhuHai Cardionovum Medical Device Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2016
Completion date
June 30, 2019
Enrollment
161 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

fistula, peripheral arterial disease